# Affluent Medical signs agreements with Edwards Lifesciences for mitral valve technologies

Affluent Medical signed several agreements with Edwards Lifesciences on July 12, 2024, for its mitral valve technologies, including an exclusive option to acquire Kephalios, a license for biomimetic cardiac mitral valve replacement technology, and an equity stake, with EUR 15 million upfront payment.

- Type: Contract
- Announced: 2024-07-12
- Where: Aix-en-Provence, France
- Value: $16.4M (15.0M EUR)
- Status: completed
- Products: adjustable mitral annulus Kalios, mitral valve technology
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [Affluent Medical](https://endata.com/companies/78572.md)
- [Edwards Lifesciences](https://endata.com/companies/5656.md) (customer)

## Sources

- [live.euronext.com](https://live.euronext.com/en/products/equities/company-news/2024-07-12-affluent-medical-signs-agreements-mitral-valve), 2024-07-12: "Affluent Medical signs agreements for mitral valve technologies with EUR 15M upfront payment."
- [massdevice.com](https://www.massdevice.com/affluent-medical-15m-valve-deal-edwards/), 2024-07-12: "We are proud to sign these agreements with the global leader in structural heart innovation."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.